Senior Scientist @ AMRI (Albany Molecular Research Inc.)
Ph.D. @ University of Nebraska Medical Center
Intern @ Boehringer Ingelheim
Education:
@
University of Pune
About:
• Experience in formulation and analytical development
• Injectable and oral formulations: small molecules and therapeutic proteins
• Pre-formulation of chemical entity and stability testing of final formulation
• Analytical and biophysical skills: HPLC, FPLC, GPC, LC-MS/MS, UV/Vis/CD spectroscopy,
Spectrofluorimetry, DLS, DSC, Rheometer, LOD, Dissolution, 1H-NMR, Light and confocal
microscopy, Flow cytometry, SDS-PAGE, Western blot, Lyophilization, SPE
• Experience in formulation and analytical development
• Injectable and oral formulations: small molecules and therapeutic proteins
• Pre-formulation of chemical entity and stability testing of final formulation
• Analytical and biophysical skills: HPLC, FPLC, GPC, LC-MS/MS, UV/Vis/CD spectroscopy,
Spectrofluorimetry, DLS, DSC, Rheometer, LOD, Dissolution, 1H-NMR, Light and confocal
microscopy, Flow cytometry, SDS-PAGE, Western blot, Lyophilization, SPE etc.
• Polymer synthesis, purification and characterization
• Advanced knowledge of statistical software Graphpad Prism, Chemstation, Unicorn, Microsoft
office, Adobe Photoshop, Chemdraw, Image J, SPSS, Compusyn, etc.
• Familiar with GLP/GMP
• Excellent written and communication skills.
Senior Research Scientist @ Pharmaceutical Development From November 2015 to Present (2 months) Ph.D. @ 1. Synthesis, purification and characterization of antibody-conjugated nanogels (Injectable formulation) and its evaluation for anti-cancer activity against Her2-overexpressing breast cancer models.
2. Development of targeted biodegradable hybrid polymer micelles (injectable formulation) for combination drug therapy in ovarian cancer. From August 2010 to October 2015 (5 years 3 months) Intern @ • Conducted cGMP drug product stability and optimized formulation for long-term stability
• Developed analytical method for isolation of degradants (generated during stability testing) in oral
formulation using preparative HPLC and solid phase extraction
• Successfully identified degradants and pathways of degradation in the formulation by using LC-
MS/MS From June 2014 to September 2014 (4 months) Columbus, Ohio AreaResearch Associate @ • Performed formulation development and scale-up of sustained-release solid dosage forms for
various small molecules
• Optimized process parameters like excipient, granulation, compression and film coating for
IVIVC
• Conducted technology transfer of one of the formulation to the client company From October 2009 to May 2010 (8 months)
PhD, Pharmaceutical science @ University of Nebraska Medical Center From 2010 to 2015 M.Pharm, Pharmaceutics @ AISSMS College of pharmacy From 2007 to 2009 Swapnil Desale is skilled in: Regulatory Affairs, Pharmaceutical Industry, Pharmacokinetics, Pharmaceutics, LC-MS, UV/Vis, HPLC, Drug Delivery, Validation, Pharmacology, Cell Culture, In Vivo, In Vitro, Western Blotting, Confocal Microscopy
Looking for a different
Swapnil Desale?
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension